TP53 and laryngotracheoesophageal cleft: In our previous studies, we evaluated a 9G DNA chip-based autoantibody detection method to identify the AICs and antigens against each CYFRA 21-1 and p53 in LC patients, demonstrating their potential usefulness in LC diagnosis with high sensitivity and specificity among other candidate biomarkers [27,28,29,30].